| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/23/2001 | EP1100934A1 Herpesvirus preparations and their uses |
| 05/23/2001 | EP1100933A1 New caspase homologue |
| 05/23/2001 | EP1100932A2 Method for autoactivation of procaspase 8 |
| 05/23/2001 | EP1100931A2 Nucleic acid module coding for alpha glucosidase, plants that synthesize modified starch, methods for the production and use of said plants, and modified starch |
| 05/23/2001 | EP1100930A1 Method to alter the fatty acid metabolism in plants |
| 05/23/2001 | EP1100929A1 Identification and functional characterization of a novel ribosomal s6 protein kinase |
| 05/23/2001 | EP1100928A2 Enzymes for biopolymer production |
| 05/23/2001 | EP1100927A2 Methods for making polyketides using altered pks |
| 05/23/2001 | EP1100926A1 TRIMER OF HIV $i(ENV) GENE EXPRESSION PRODUCT |
| 05/23/2001 | EP1100925A1 Attenuated equine herpesvirus |
| 05/23/2001 | EP1100924A1 Polynucleotide transporter protein |
| 05/23/2001 | EP1100923A2 Thermostable in vitro complex with polymerase activity |
| 05/23/2001 | EP1100922A1 Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine |
| 05/23/2001 | EP1100921A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/23/2001 | EP1100920A2 Nucleic acids and proteins from group b streptococcus |
| 05/23/2001 | EP1100919A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 05/23/2001 | EP1100918A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/23/2001 | EP1100917A1 Granulocytic ehrlichia genes and uses thereof |
| 05/23/2001 | EP1100916A2 Composition for implementing a cytotoxic, in particular an antitumoral or antiviral, treatment in a mammal |
| 05/23/2001 | EP1100915A2 Fibrous proteins and the production thereof |
| 05/23/2001 | EP1100914A2 Novel genes in control of hematopoiesis |
| 05/23/2001 | EP1100913A1 Mekk1 serine threonine kinases -interacting fha forkhead associated domain protein 1 (mif1) |
| 05/23/2001 | EP1100912A1 Method for screening of modulators of calcineurin activity |
| 05/23/2001 | EP1100911A1 Eukaryotic cell-based gene interaction cloning |
| 05/23/2001 | EP1100910A1 Dna encoding a human inhibitor-of-apoptosis protein; hiap3 |
| 05/23/2001 | EP1100909A2 Dna replication- and repair-associated proteins |
| 05/23/2001 | EP1100908A2 Human receptor-associated proteins |
| 05/23/2001 | EP1100907A2 Human cytoskeletal proteins |
| 05/23/2001 | EP1100906A1 Kdel receptor inhibitors |
| 05/23/2001 | EP1100905A2 Human epidermal proteins hepi-1 to hepi-6 |
| 05/23/2001 | EP1100904A2 Phosphorylation effectors |
| 05/23/2001 | EP1100903A1 Pb 39, a gene dysregulated in prostate cancer, and uses thereof |
| 05/23/2001 | EP1100902A1 Keratinocyte derived interferon |
| 05/23/2001 | EP1100901A1 Tumor associated antigen peptides and use of same as anti-tumor vaccines |
| 05/23/2001 | EP1100900A2 Xiap ires and uses thereof |
| 05/23/2001 | EP1100899A2 Delta-related polypeptides |
| 05/23/2001 | EP1100898A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 05/23/2001 | EP1100897A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 05/23/2001 | EP1100896A1 Dna encoding snorf33 receptor |
| 05/23/2001 | EP1100895A2 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 05/23/2001 | EP1100894A2 Short oligonucleotides for the inhibition of vegf expression |
| 05/23/2001 | EP1100893A1 Nucleic acids encoding proteins involved in sensory transduction |
| 05/23/2001 | EP1100892A1 Use of prohibitin rna in treatment of cancer |
| 05/23/2001 | EP1100891A2 Expression of functional eukaryotic proteins |
| 05/23/2001 | EP1100890A2 Improved transformation efficiency in phage display through modification of a coat protein |
| 05/23/2001 | EP1100889A1 Micellar systems |
| 05/23/2001 | EP1100888A2 System for reproducing and modulating stability and turnover of rna molecules |
| 05/23/2001 | EP1100887A1 Growth differentiation factor-11 |
| 05/23/2001 | EP1100886A1 Tumor necrosis factor-gamma |
| 05/23/2001 | EP1100885A1 Rapid subcloning using site-specific recombination |
| 05/23/2001 | EP1100884A1 Hybrid yeast-bacteria cloning system and uses thereof |
| 05/23/2001 | EP1100883A2 Map kinase phosphatase mutant |
| 05/23/2001 | EP1100882A1 Human protein kinase h2lau20 |
| 05/23/2001 | EP1100881A1 Recombinant dehydrodiconiferyl alcohol benzylic ether reductase, and methods of use |
| 05/23/2001 | EP1100880A2 Urate oxidase |
| 05/23/2001 | EP1100879A1 Pneumococcal nrdg protein |
| 05/23/2001 | EP1100878A2 Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy |
| 05/23/2001 | EP1100876A1 Agrobacterium-mediated transformation of turfgrass |
| 05/23/2001 | EP1100873A1 Cancer cells from body fluids containing cells, isolation thereof and agents containing the same |
| 05/23/2001 | EP1100872A1 Method for maintenance and propagation of germline stem cells using members of the tgf-beta family of growth factors |
| 05/23/2001 | EP1100869A1 98 human secreted proteins |
| 05/23/2001 | EP1100830A2 Heterominibodies |
| 05/23/2001 | EP1100828A1 Antibodies against beer spoilage lactic acid bacteria and their diagnostic use |
| 05/23/2001 | EP1100826A1 Isoforms of human calcium sensing receptor |
| 05/23/2001 | EP1100825A1 Human mink gene mutations associated with arrhythmia |
| 05/23/2001 | EP1100822A1 Secreted cysteine rich protein-6 (scrp-6) |
| 05/23/2001 | EP1100819A2 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2) |
| 05/23/2001 | EP1100817A1 Endogenous retrovirus tumor associated nucleic acids and antigens |
| 05/23/2001 | EP1100815A1 Protease susceptibility ii |
| 05/23/2001 | EP1100813A1 HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb |
| 05/23/2001 | EP1100811A1 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction |
| 05/23/2001 | EP1100810A1 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction |
| 05/23/2001 | EP1100808A1 Prostate derived ets factor |
| 05/23/2001 | EP1100807A1 STEREOISOMERS OF CpG OLIGONUCLEOTIDES AND RELATED METHODS |
| 05/23/2001 | EP1100548A2 Genetically engineered cells and tissues |
| 05/23/2001 | EP1100547A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 05/23/2001 | EP1100545A1 Regulated expression of recombinant proteins using rna viruses |
| 05/23/2001 | EP1100542A2 Peg-urate oxidase conjugates and use thereof |
| 05/23/2001 | EP1100538A2 Kvlqt1 - a long qt syndrome |
| 05/23/2001 | EP1100535A1 Targeting pharmaceutical agents to injured tissues |
| 05/23/2001 | EP1100533A2 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof |
| 05/23/2001 | EP1100521A1 C7f2-a novel potassium channel beta-subunit |
| 05/23/2001 | EP1100510A2 Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism |
| 05/23/2001 | EP1100464A1 Lipid emulsion and solid lipid nanoparticle as a gene or drug carrier |
| 05/23/2001 | EP1100429A2 Apoptosis proteins |
| 05/23/2001 | EP1100311A1 Novel genetic materials for transmission into maize |
| 05/23/2001 | EP1100310A1 Plants, seeds and oils having an elevated total monounsaturated fatty acid content |
| 05/23/2001 | EP1100308A1 Copper transporter in ethylene signaling pathway |
| 05/23/2001 | EP1012255A4 Enhancement of growth in plants |
| 05/23/2001 | EP0986533A4 Identification of a unique receptor specific for a particular retinoid inducing cellular apoptosis |
| 05/23/2001 | EP0932622A4 Vitamin d response element binding protein |
| 05/23/2001 | EP0701127B1 Method of testing neurotoxicity of poliovirus vaccine |
| 05/23/2001 | EP0699248B1 Methods for treating non-cotton-containing cellulosic fabrics with cellulase |
| 05/23/2001 | EP0689600B1 Process to induce the death of tumor cells |
| 05/23/2001 | EP0667900B1 Introns and exons of the cystic fibrosis gene and mutations at various positions of the gene |
| 05/23/2001 | EP0623170B1 Vaccines based on streptokinase |
| 05/23/2001 | EP0572433B1 Antigen-presenting capsid with fusion ms2-coat protein |
| 05/23/2001 | EP0215907B1 Parasite-derived resistance |
| 05/23/2001 | DE19956029A1 Active substance carrier system based on coating a substance with enzymatically cleavable side groups, useful for gene therapy especially of cancer and inflammation |
| 05/23/2001 | DE19955605A1 Cytochrome P450 monooxygenase for oxidizing organic compounds, useful especially for converting indole to indigo, has wide substrate range |